FDA Inspection 954606 — Solace Therapeutics, Inc.
The FDA completed an inspection of Solace Therapeutics, Inc. on January 5, 2016 in Framingham, MA. The inspection was classified NAI (No Action Indicated — no objectionable conditions were found). Product area: Devices.
Inspection Details
- Classification
- No Action Indicated (NAI) (NAI)
- End Date
- January 5, 2016
- Fiscal Year
- 2016
- Product Type
- Devices
- Project Area
- Bioresearch Monitoring
- Location
- Framingham, MA (United States)
Additional Details
Sponsor, Contract Research Organization